- Report
- October 2021
- 112 Pages
India
From €3640EUR$3,712USD£3,033GBP
- Report
- August 2021
- 195 Pages
Global
From €3640EUR$3,712USD£3,033GBP
- Book
- April 2019
- 240 Pages
- Book
- February 2012
- 216 Pages
- Book
- April 2010
- 192 Pages
- Book
- August 2018
- 352 Pages
- Book
- August 2022
North America
- Report
- October 2024
- 141 Pages
Poland
From €1765EUR$1,800USD£1,471GBP
The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more